278
W. T. Woo et al.
Table 1
(continued)
SDG
Projects
Partners
Relevance/Implication
Findings/Outcome
SDG 3: Good health
and well being
Efficacy of
genetically-modified (GM)
Oxitec mosquitoes for
dengue eradication
• Sunway University
• USM
• MOH, Ministry of Health Malaysia
• To assess the effectiveness of release of
Oxitec GM mosquitoes for controlling
mosquito population
• The use of GM mosquitoes is not
sustainable economically and not
feasible logistically
• It is recommended that the Oxitec GM
release experiments in Malaysia be
terminated. MOH accepted
recommendation
• Further, ecological impact of the release
not well-studied
Pharmacoeconomics study
for Malaysia
• Sunway University
• MOH
• USM
• To appraise dengue vaccine Dengvaxia
implementation in Malaysia
• To evaluate and provide
recommendations on the most
cost-effective price per dose of dengue
vaccine Dengvaxia by Sanofi Pasteur
• Recommended a set of five criteria
consisting of safety, efficacy, social
equity, affordability and
cost-effectiveness as a basis for
evaluation
• The current version of Dengvaxia has a
hidden danger for seronegative
individuals
• Conditional registration of Dengvaxia in
Malaysia
• Vaccine price is the most important
factor, once the vaccine safety and
efficacy are assured
• Recommended dengue vaccine pricing
threshold for Malaysia: USD5 per dose
(continued)